Skip to content
Home
LIVE · CORPUS
Dossier

Viking Global Opportunities GP LLC

Low
PersonUS
The finding

Controls or directs 29 companies in the resolved graph.

/01

Key facts

Risk signal
Controls
29 companies
Risk
Low
Jurisdiction
US

Viking Global Opportunities GP LLC controls or directs 29 companies (US).

/02

Control & directorships

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Controlled by

None in current sources.

Directorships & controlled companies
/03

Directorship network

983 other roles

Where this entity’s officers also hold (or held) positions — the wider network reached through shared people. Roles are registry records, not a claim of control.

ACUREN CORP
BridgeBio Pharma, Inc.
INHIBRX, INC.
APi Group Corp
STANDARD BIOTOOLS INC.
4D Molecular Therapeutics, Inc.
RAYZEBIO, INC.
Roivant Sciences Ltd.
Rallybio Corp
FRAZIER LIFESCIENCES ACQUISITION CORP
Amylyx Pharmaceuticals, Inc.
Ginkgo Bioworks Holdings, Inc.
PROCEPT BioRobotics Corp
FIGS, Inc.
Adaptive Biotechnologies Corp
Zentalis Pharmaceuticals, Inc.
Arbutus Biopharma Corp
AXOVANT GENE THERAPIES LTD.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on Viking Global Opportunities GP LLC. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnakeScore.

Sign in to contribute a tip and earn reputation — it's free.
Loading tips…